148583-58-8

Basic information

• Product Name: Piperidine, 4-[2-(1-methylethoxy)phenyl]-
• Synonyms: 4-(2-Isopropoxy-phenyl)-piperidine;4-(2-isopropoxyphenyl)piperidine
• CAS NO: 148583-58-8
• Molecular Formula: C14H21NO
• Molecular Weight: 219.32300
• Mol File: 148583-58-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Piperidine, 4-[2-(1-methylethoxy)phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Piperidine, 4-[2-(1-methylethoxy)phenyl]-(148583-58-8)
• EPA Substance Registry System: Piperidine, 4-[2-(1-methylethoxy)phenyl]-(148583-58-8)

Safety Data

• Hazardous Substances Data: 148583-58-8(Hazardous Substances Data)

Upstream product

• 148583-61-3 1-Carbethoxy-4-[2-(1-methylethoxy)phenyl]-4-piperidinol 
• 29976-53-2 N-ethoxycarbonyl-4-piperidone 
• 701-07-5 1-bromo-2-isopropoxybenzene 
• 95-56-7 2-hydroxybromobenzene 
• 946605-56-7 C₁₉H₂₉NO₄ 
• 174822-94-7 C₁₉H₂₉NO₃ 
• 148583-62-4 1-carbethoxy-4-[2-(1-methylethoxy)phenyl]piperidine 

Downstream Products

• 910605-22-0 N-trans-{4-[4-(2-isopropoxy-phenyl)-piperidin-1-yl]-cyclohexyl}-3,4-dimethoxy-benzenesulfonamide 
• 910605-21-9 JNJ-26218127 
• 910605-24-2 4-[4-(2-isopropoxy-phenyl)-piperidin-1-yl]-cyclohexylamine 

Relevant articles and documents

(Phenylpiperidinyl)cyclohexylsulfonamides: Development of α1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS)

Although α1 adrenergic receptor blockers can be very effective for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS), their usage is limited by CV-related side-effects that are caused by the subtype non-selec